Table 1.
Patients’ baseline characteristics divided according to liver abscess
| Characteristics | Total (n = 137) | LA (n = 12) | Non-LA (n = 125) |
|---|---|---|---|
| Age (year), median (range) | 58 (28–81) | 55 (39–73) | 59 (28–81) |
| Male gender, n (%) | 73 (53.3%) | 7 (58.3%) | 66 (52.8%) |
| Comorbilities | |||
| Diabetes mellitus, n (%) | 8 (5.8%) | 2 (16.7%) | 6 (4.8%) |
| Chronic liver disease, n (%) | 10 (7.3%) | 3 (25%) | 7 (5.6%) |
| Biliaryenteric anastomosis, n (%) | 5 (3.6%) | 1 (8.3%) | 4 (3.2%) |
| ECOG score | |||
| 0 | 123 (89.8%) | 10 (83.3%) | 113 (90.4%) |
| 1 | 14 (10.2%) | 2 (16.7%) | 12 (9.6%) |
| Child-Pugh classification | |||
| Child-Pugh A, n (%) | 128 (93.4%) | 10 (83.3%) | 118 (94.4%) |
| Child-Pugh B, n (%) | 9 (6.6%) | 2 (16.7%) | 7 (5.6%) |
| WBC (×109/L ), median (range) | 6.4 (2.9–10.7) | 6.1 (4.9–9.2) | 6.5 (2.9–10.7) |
| Primary tumor | |||
| Colorectal cancer, n (%) | 63 (46.0%) | 5 (41.7%) | 58 (46.4%) |
| Gastric cancer, n (%) | 24 (17.5%) | 3 (25.0%) | 21 (16.8%) |
| Lung cancer, n (%) | 19 (13.9%) | 2 (16.7%) | 17 (13.6%) |
| Breast cancer, n (%) | 16 (11.7%) | 0 | 16 (12.8%) |
| Nasopharyngeal carcinoma, n (%) | 10 (7.3%) | 1 (8.3%) | 9 (7.2%) |
| Neuroendocrine neoplasm, n (%) | 4 (2.9%) | 0 | 4 (3.2%) |
| Pancreas carcinoma, n (%) | 1 (0.7%) | 1 (8.3%) | 0 |
| Tumor number | |||
| 1, n (%) | 11 (8.0%) | 1 (8.3%) | 10 (8.0%) |
| 2, n (%) | 29 (21.2%) | 4 (33.3%) | 25 (20.0%) |
| 3 or more, n (%) | 97 (70.8%) | 7 (58.3%) | 90 (72.0%) |
| MTD (cm), median (range) | 5.2 (3–11) | 6.7 (4–9) | 4.9 (3–11) |
| Portal vein thrombosis | |||
| No, n (%) | 129 (94.2%) | 10 (83.3%) | 119 (95.2%) |
| Branch, n (%) | 7 (5.1%) | 2 (16.7%) | 5 (4.0%) |
| Main, n (%) | 1 (0.7%) | 0 | 1 (0.8%) |
| Antibiotic prophylaxis | |||
| No, n (%) | 129 (94.2%) | 11 (91.7%) | 118 (94.4%) |
| Yes, n (%) | 8 (5.8%) | 1 (8.3%) | 7 (5.6%) |
| SC before DEB-TACE | |||
| No, n (%) | 6 (4.4%) | 1 (8.3%) | 5 (4.0%) |
| Within 3 months, n (%) | 9 (6.6%) | 6 (50.0%) | 3 (2.4%) |
| More than 3 months, n (%) | 122 (89.1%) | 5 (41.7%) | 117 (93.6%) |
| Selectivity of embolization | |||
| Lobar, n (%) | 4 (2.9%) | 1 (8.3%) | 3 (2.4%) |
| Segmental, n (%) | 22 (16.1%) | 3 (25.0%) | 19 (15.2%) |
| Sub segmental, n (%) | 111 (81%) | 8 (66.7%) | 103 (82.4%) |
| Degree of artery occlusion | |||
| Grade 0, n (%) | 124 (90.5%) | 2 (16.7%) | 122 (97.6%) |
| Grade 1, n (%) | 13 (9.5%) | 10 (83.3%) | 3 (2.4%) |
LA, liver abscess; WBC, white blood cells; MTD, maximum tumor diameter; SC, systemic chemotherapy; DEB-TACE, drug-eluting bead chemoembolization.